Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
L. A. Smith(EES Research (United Kingdom)), Alison Jones(Roche (Switzerland)), Chris Plummer(Newcastle upon Tyne Hospitals NHS Foundation Trust), Peter Canney(Beatson West of Scotland Cancer Centre), Gill Levitt(Great Ormond Street Hospital for Children NHS Foundation Trust), Victoria Cornelius(Imperial College London), Mark Verrill(Newcastle upon Tyne Hospitals NHS Foundation Trust)
Cited by 755
Related Papers
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
|Journal of Clinical Oncology|2009|850
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|The Lancet Oncology|2015|561
A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group
|Pediatric Blood & Cancer|2012|361
Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
|British Journal of Cancer|1984|319
Chemotherapy for Breast Cancer During Pregnancy: An 18-Year Experience From Five London Teaching Hospitals
|Journal of Clinical Oncology|2005|278